Lifecome Biochemistry Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Dec '21 Dec 31, 2021
Cash & Equivalents	55.6	24.8	84.38	23.76	97.5
Cash & Short-Term Investments	55.6	24.8	84.38	23.76	97.5
Cash Growth	124.20%	-70.61%	255.14%	-75.63%	-49.81%
Accounts Receivable	42.64	76.83	128.42	60.06	44.86
Other Receivables	9.35	17.52	59.82	2.76	19.56
Receivables	51.99	94.36	188.24	62.82	64.42
Inventory	95.48	95.71	201.89	89.06	61.2
Other Current Assets	4.62	1.36	3.87	330.16	4.86
Total Current Assets	207.68	216.22	478.39	505.8	227.97
Property, Plant & Equipment	474.44	1,062	1,150	633.54	907.87
Long-Term Investments	32.46	51.65	44.75	48.57	59.14
Goodwill	-	-	61.6	-	-
Other Intangible Assets	21.08	125.58	132.21	31.4	40.86
Long-Term Deferred Tax Assets	11.42	11.05	30.96	7.47	9.15
Long-Term Deferred Charges	0.02	12.49	0.8	0.19	2.03
Other Long-Term Assets	1.62	12.49	66.79	12.9	11.39
Total Assets	748.71	1,492	1,965	1,240	1,258
Accounts Payable	102.52	315.72	310.09	136.11	167.7
Accrued Expenses	7.2	17.12	12.56	7.95	9.79
Short-Term Debt	306.72	296.76	387.77	202.93	156.28
Current Portion of Long-Term Debt	170.83	479.08	85.47	41.71	37.16
Current Portion of Leases	-	4.36	1.31	0.08	0.07
Current Unearned Revenue	4.92	17.06	1.51	2.81	0.91
Other Current Liabilities	5.05	112.6	131.61	93.54	18.42
Total Current Liabilities	597.24	1,243	930.31	485.14	390.34
Long-Term Debt	30	133.92	490.25	105.88	96.99
Long-Term Leases	-	35.47	121.9	45	30.69
Long-Term Unearned Revenue	1.94	30.02	3.47	4.32	9.63
Long-Term Deferred Tax Liabilities	-	3.46	4.96	0.22	8.73
Other Long-Term Liabilities	54.6	70.63	-	-	-
Total Liabilities	683.78	1,516	1,551	640.56	536.38
Common Stock	155.42	155.42	155.42	155.42	155.42
Additional Paid-In Capital	576.51	349.47	345.46	340.47	340.47
Retained Earnings	-669.15	-538.36	-93.5	128.32	250.26
Treasury Stock	-	-	-	-32.43	-32.43
Comprehensive Income & Other	0.41	7.2	3.91	3.91	3.91
Total Common Equity	63.18	-26.27	411.29	595.69	717.63
Minority Interest	1.75	1.73	2.82	3.61	4.4
Shareholders' Equity	64.93	-24.54	414.11	599.3	722.02
Total Liabilities & Equity	748.71	1,492	1,965	1,240	1,258
Total Debt	507.55	949.6	1,087	395.6	321.19
Net Cash (Debt)	-451.94	-924.8	-1,002	-371.84	-223.7
Net Cash Per Share	-2.92	-5.95	-6.51	-2.41	-1.46
Filing Date Shares Outstanding	155.42	155.42	155.42	153.4	153.4
Total Common Shares Outstanding	155.42	155.42	155.42	153.4	153.4
Working Capital	-389.55	-1,026	-451.92	20.66	-162.36
Book Value Per Share	0.41	-0.17	2.65	3.88	4.68
Tangible Book Value	42.1	-151.84	217.48	564.29	676.77
Tangible Book Value Per Share	0.27	-0.98	1.40	3.68	4.41
Buildings	388.09	543.18	479.28	406.53	206.45
Machinery	579.72	890.18	657.2	585.29	310.2
Construction In Progress	5.52	55.9	410.78	6.2	709.64

Source: S&P Global Market Intelligence. Standard template. Financial Sources.